Xuan Wang
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- Cancer Research top 10%
- Surgery top 5%
- Bladder and Urothelial Cancer Treatments 13
-
- Lung Cancer Diagnosis and Treatment 12
- Prostate Cancer Diagnosis and Treatment 11
- Prostate Cancer Treatment and Research 11
- Rehabilitation top 5%
-
- Epigenetics and DNA Methylation 13
- Cancer-related gene regulation 8
-
- Radiomics and Machine Learning in Medical Imaging 11
- Cited by
- OncologyCancer ResearchSurgery
- Journals
- Circulation (1 paper)Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xuan Wang
151 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 412
- Cancer Research 210
- Surgery 613
- Pulmonary and Respiratory Medicine 421
- Rehabilitation 85
Countries citing papers authored by Xuan Wang
This map shows the geographic impact of Xuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Wang more than expected).
Fields of papers citing papers by Xuan Wang
This network shows the impact of papers produced by Xuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Wang. The network helps show where Xuan Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 21 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 19 | |
| 13 | 2020 | 20 | |
| 14 | 2019 | 28 | |
| 15 | 2018 | 6 | |
| 16 | 2018 | 7 | |
| 17 | 2015 | 1 | |
| 18 | 2010 | 3 | |
| 19 | Pathohistological studies on ducks infected with NDV of duck origin | 2010 | 2 |
| 20 | A study on yeasts of Yunnan.I.Yeasts of tropical rain forest, Xishuangbanna | 2002 | 1 |
About Xuan Wang
Xuan Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 167 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Epigenetics and DNA Methylation (13 papers), Lung Cancer Diagnosis and Treatment (12 papers), Radiomics and Machine Learning in Medical Imaging (11 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Oncology (412 citations), Cancer Research (210 citations) and Surgery (613 citations). Xuan Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Elaine Fuchs, Trevor Williams, Bin Xu, Chong-Xi Yuan, Zhi Yu, Gang Shi, Ying Xia, H. Amalia Pasolli, Donghao Lu and Ming Liu. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.